Researchers are engaged on extremely-extended-performing GLP-1 analogs that may have to have dosing just once a month and even considerably less frequently. These prolonged-launch versions could help it become even simpler to keep on with getting GLP-1s.  Semaglutide and tirzepatide are at present the most popular choices for fat reduction and ty